Abstract:Cancer is generally regarded as a localised disease, with the well-established role of the tumour microenvironment. However, the realm of cancer goes beyond the tumour microenvironment, and cancer should also be regarded as a systemic and environmental disease. The exposome ( ie, the totality of exposures), which encompasses diets, supplements, smoking, alcohol, other lifestyle factors, medications, etc , likely alters the microbiome (inclusive of bacteria, viruses, archaea, fungi, parasites, etc ) and immune system in various body sites and influences tumour phenotypes. The systemic metabolic/inflammatory status, which is likely influenced by exposures and intestinal physiological changes, may affect tissue microenvironment of colorectum and any other organs. Germline genomic factors can modify disease phenotypes via gene-by-environment interactions. Although challenges exist, it is crucial to advance not only basic experimental research that can analyse the effects of exposures, microorganisms and microenvironmental components on tumour evolution but also interdisciplinary human population research that can dissect the complex pathogenic roles of the exposome, microbiome and immunome. Metagenomic, metatranscriptomic and metabolomic analyses should be integrated into well-designed population research combined with advanced methodologies of artificial intelligence and molecular pathological epidemiology. Ideally, a prospective cohort study design that enables biospecimen (such as stool) collection before disease detection should be considered to address reverse causation and recall biases. Robust experimental and observational research together can provide insights into dynamic interactions between environmental exposures, microbiota, tumour and immunity during carcinogenesis processes, thereby helping us develop precision prevention and therapeutic strategies to ultimately reduce the cancer burden.

Bodywide ecological interventions on cancer

Cancer and the Metaorganism

Cytokines and soluble mediators as architects of tumor microenvironment reprogramming in cancer therapy

Exploiting ecological principles to better understand cancer progression and treatment

Microbiota Manipulation as an Emerging Concept in Cancer Therapy

Concepts Collide: Genomic, Immune, and Microbial Influences on the Tumor Microenvironment and Response to Cancer Therapy

Cancer neuroscience at the brain-body interface

Microbiota in cancer: molecular mechanisms and therapeutic interventions

Microbiome Crosstalk in Immunotherapy and Antiangiogenesis Therapy

The Emerging Tumor Microbe Microenvironment: from Delineation to Multidisciplinary Approach-Based Interventions

The Theory of Tumor Ecosystem

Bridging brain and body in cancer

Cancer as microenvironmental, systemic and environmental diseases: opportunity for transdisciplinary microbiomics science

The Microbiome in Cancer Immunotherapy: Diagnostic Tools and Therapeutic Strategies

Contribution of Aging, Obesity, and Microbiota on Tumor Immunotherapy Efficacy and Toxicity

Metabolic Interplay in the Tumor Microenvironment: Implications for Immune Function and Anticancer Response

Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments

New horizons in tumor microenvironment biology: challenges and opportunities

The Impact of Gut Microbiota-Derived Metabolites on the Tumor Immune Microenvironment

Therapy-induced microenvironmental changes in cancer

Navigating the complex relationship between human gut microbiota and breast cancer: Physiopathological, prognostic and therapeutic implications